AI in Drug Repurposing Market Projected to Reach $7.7 Billion by 2033
The artificial intelligence drug repurposing market is forecasted to grow at a 24.5% CAGR, reaching USD 7.7 billion by 2033. Driven by advancements in precision medicine and cloud adoption, AI significantly reduces drug development time, costs, and clinical risks by efficiently analyzing complex multi-omics and patient data for pharmaceutical research.
Source: Yahoo Finance